Active substanceDiclofenacDiclofenac
Similar drugsTo uncover
  • Argett Duo
    capsules inwards 
  • Argett Rapid
    capsules
  • Voltaren®
    patch externally 
  • Voltaren®
    patch externally 
  • Voltaren®
    spray externally 
  • Voltaren®
    suppositories rect. 
    Novartis Pharma AG     Switzerland
  • Voltaren®
    pills inwards 
  • Voltaren®
    pills inwards 
    Novartis Pharma AG     Switzerland
  • Voltaren®
    solution w / m 
    Novartis Pharma AG     Switzerland
  • Voltaren®-Flotac®
    capsules inwards 
    Novartis Pharma AG     Switzerland
  • Voltaren® Acti
    pills inwards 
  • Voltaren® Ophta
    drops d / eye 
  • Voltaren Rapid
    powder inwards 
    Novartis Pharma AG     Switzerland
  • Voltaren Rapid
    pills inwards 
    Novartis Pharma AG     Switzerland
  • Voltaren® Emulgel®
    gel externally 
  • Voltaren® Emulgel®
    gel externally 
  • Diclac®
    pills inwards 
    Sandoz d.     Slovenia
  • Diclac®
    suppositories rect. 
    Sandoz d.     Slovenia
  • Diclac®
    solution w / m 
    Sandoz d.     Slovenia
  • Diclac®
    gel externally 
    Sandoz d.     Slovenia
  • Diclac® Lipogel
    gel externally 
    Sandoz d.     Slovenia
  • Diklo-F
    drops d / eye 
  • Diklovit®
    gel externally 
  • Diklovit®
    suppositories rect. 
  • Diklogen®
    pills inwards 
  • Diklogen®
    gel externally 
  • Diklogen®
    pills inwards 
  • Diklogen®
    solution w / m 
  • Diklogen®
    gel externally 
  • Diclonat® P
    solution w / m 
  • Dicloran®
    gel externally 
  • Diclofenac
    suppositories rect. 
    FARMENT FIRM, LLC     Russia
  • Diclofenac
    solution w / m 
    GROTEKS, LLC     Russia
  • Diclofenac
    drops d / eye 
    SYNTHESIS, OJSC     Russia
  • Diclofenac
    pills inwards 
    SYNTHESIS, OJSC     Russia
  • Diclofenac
    ointment externally 
  • Diclofenac
    suppositories rect. 
  • Diclofenac
    gel externally 
  • ATOLL, LLC     Russia
  • Diclofenac
    solution w / m 
    ATOLL, LLC     Russia
  • Diclofenac
    solution w / m 
    ELLARA, LTD.     Russia
  • Diclofenac
    solution w / m 
    ALVILS, LTD.     Russia
  • Diclofenac
    solution w / m 
  • Diclofenac
    gel externally 
  • Diclofenac
    pills inwards 
    BIOSINTEZ, PAO     Russia
  • Diclofenac
    ointment externally 
    ATOLL, LLC     Russia
  • Diclofenac
    solution w / m 
    DALHIMFARM, OJSC     Russia
  • Diclofenac
    ointment
    GREEN DUBRAVA, CJSC     Russia
  • Diclofenac
    suppositories
    ALTAYVITAMINS, CJSC     Russia
  • Diclofenac
    pills inwards 
  • Diclofenac
    solution w / m 
  • Diclofenac
    suppositories rect. 
    BIOSINTEZ, PAO     Russia
  • Diclofenac
    solution w / m 
  • Diclofenac
    gel externally 
  • Diclofenac
    pills inwards 
  • Diclofenac
    solution w / m 
  • Diclofenac
    suppositories rect. 
  • Diclofenac
    gel externally 
    ELFA NPC, CJSC     Russia
  • Diclofenac
    suppositories rect. 
    DALHIMFARM, OJSC     Russia
  • Diclofenac
    solution w / m 
  • Diclofenac
    ointment externally 
  • Diclofenac
    pills inwards 
    ZIO-HEALTH, JSC     Russia
  • Diclofenac
    solution w / m 
  • Diclofenac
    solution w / m 
    Hanmi Farm. Co., Ltd     The Republic of Korea
  • Diclofenac
    pills inwards 
  • Diclofenac
    pills inwards 
  • Diclofenac
    drops d / eye 
  • Diclofenac
    solution w / m 
  • Diclofenac
    pills inwards 
  • Diclofenac
    pills inwards 
  • Diclofenac
    solution
  • Diclofenac
    suppositories rect. 
    Magister KiK     Romania
  • Diclofenac
    gel externally 
    Hemofarm AD     Serbia
  • Diclofenac
    solution w / m 
    BIOSINTEZ, PAO     Russia
  • Diclofenac
    ointment externally 
    BIOSINTEZ, PAO     Russia
  • Diclofenac
    pills inwards 
    Natur Product Europe BV     Netherlands
  • Diclofenac
    suppositories rect. 
    FARMAPRIM, LLC     The Republic of Moldova
  • Diclofenac
    solutionpills inwards w / m 
  • Diclofenac
    pills inwards 
    OZONE, LLC     Russia
  • Diclofenac
    drops d / eye 
  • Diclofenac
    pills inwards 
    VALENTA PHARM, PAO     Russia
  • Diclofenac
    solution w / m 
  • Diclofenac
    gel externally 
    SYNTHESIS, OJSC     Russia
  • Diclofenac
    gel externally 
    SYNTHESIS, OJSC     Russia
  • Diclofenac
    solution w / m 
  • Diclofenac
    gel externally 
    ATOLL, LLC     Russia
  • Diclofenac
    gel externally 
  • Diclofenac Wellpharm
    solution w / m 
    VELFARM, LLC     Republic of San Marino
  • Diclofenac Grindeks
    ointment externally 
    GRINDEX, JSC     Latvia
  • Diclofenac retard
    pills inwards 
    OZONE, LLC     Russia
  • Diclofenac retard-Akrihin
    pills inwards 
    AKRIKHIN HFK, JSC     Russia
  • Diclofenac Sandoz®
    pills inwards 
    Sandoz d.     Slovenia
  • Diclofenac Sandoz®
    pills inwards 
    Sandoz d.     Slovenia
  • Diclofenac Stade®
    pills inwards 
  • Diclofenac Stade®
    pills inwards 
  • Elf Diclofenac
    solution w / m 
  • Diclofenac-Akos
    solution w / m 
    SYNTHESIS, OJSC     Russia
  • Diclofenac-Akos
    ointment externally 
    SYNTHESIS, OJSC     Russia
  • Diclofenac-Acrychin®
    gel externally 
    AKRIKHIN HFK, JSC     Russia
  • AKRIKHIN HFK, JSC     Russia
  • Diclofenac-Acrychin
    gel externally 
    AKRIKHIN HFK, JSC     Russia
  • Diclofenac-Altpharm
    suppositories rect. 
    ALTFARM, LLC     Russia
  • Diclofenac-MFF
    suppositories rect. 
  • Diclofenac-MFF
    ointment externally 
  • Diclofenac-ratopharm
    suppositories rect. 
    ratiofarm GmbH     Germany
  • Diclofenac-SOLOfarm
    drops d / eye 
    GROTEKS, LLC     Russia
  • Diclofenac-Teva
    gel externally 
  • Diclofenac-UBF
    pills inwards 
    URALBIOFARM, OJSC     Russia
  • Diclofenac-FPO
    pills inwards 
  • Diclofenac-Eskom
    solution w / m 
    ESKOM NPK, OAO     Russia
  • Diclofenaclong®
    drops d / eye 
    FIRN M, ZAO     Russia
  • Diclofenacol
    cream externally 
    Hiperion S.A.     Romania
  • Dorosan
    aerosol externally 
    Rottafarm SpA     Italy
  • Naklofen
    solution w / m 
  • Naklofen
    pills inwards 
  • Naklofen
    suppositories rect. 
  • Naklofen
    gel externally 
  • Naklofen Duo
    capsules inwards 
  • Naklofen Protect
    capsules inwards 
    KRKA-RUS, LLC     Russia
  • Naklofen SR
    pills inwards 
  • Orthophene
    gel externally 
    VERTEKS, AO     Russia
  • Orthophene
    solution w / m 
  • Orthophene
    pills inwards 
  • Orthophene
    ointment externally 
    VERTEKS, AO     Russia
  • Orthofer®
    ointment externally 
    BRYNTSALOV-A, CJSC     Russia
  • Orthofer®
    pills inwards 
    BRYNTSALOV-A, CJSC     Russia
  • Orthofer®
    solution w / m 
    BRYNTSALOV-A, CJSC     Russia
  • Penseid
    solution externally 
    NovaMedika, OOO     Russia
  • Rapten Duo
    pills inwards 
    Hemofarm AD     Serbia
  • Rapent Rapid
    pills inwards 
    Hemofarm AD     Serbia
  • Rapent Rapid
    pills inwards 
    Hemofarm AD     Serbia
  • Tabuk-Di
    pills inwards 
  • The Flector
    patch through. 
  • Dosage form: & nbsp
    Capsules are enteric-soluble.
    Composition:

    One capsule contains:

    diclofenac pellets 235,50 mg, equivalent to 75 mg of diclofenac sodium.

    Pellet composition:

    active substance: diclofenac sodium 75 mg;

    Excipients:- cellulose microcrystalline 95.61 mg, povidone-K25 15 mg, silicon dioxide colloidal anhydrous 1.89 mg.

    Pellet shell: methacrylic acid and ethyl acrylate copolymer [1: 1] (type A) 30 mg [sodium lauryl sulfate 0.7% and polysorbate 80% 2.3%], propylene glycol 3 mg, talc 15 mg;

    Capsule shell composition: titanium dioxide (E171) 0.93%, iron dye oxide red (E172) 1.32%, gelatin to 100%.

    Description:Hard gelatin capsules. The size of the capsule is No. 2. Color of capsule: body and cap of red-brown color. The contents of the capsule are pellets from white to cream colored.
    Pharmacotherapeutic group:Non-steroidal anti-inflammatory drug.
    ATX: & nbsp

    S.01.B.C.03   Diclofenac

    M.01.A.B.05   Diclofenac

    Pharmacodynamics:Has anti-inflammatory, analgesic and antipyretic effect.By indiscriminately inhibiting cyclooxygenase 1 (COX1) and cytooxygenase 2 (COX2), it breaks the metabolism of arachidonic acid, reduces the amount of prostaglandins in the inflammatory focus. The most effective for inflammatory pain. Like all non-steroidal anti-inflammatory drugs (NSAIDs), the drug has antiplatelet activity.
    Pharmacokinetics:

    Suction: after oral administration, dlclofenac is easily absorbed into the systemic circulation. Eating, does not affect, na the degree of absorption of the drug, but slows the rate of absorption. Depending on the filling of the stomach, the maximum concentration in the blood plasma (Cmax) is achieved on the average through 2-3 h. The concentration in the plasma is in linear dependence on the amount of the administered dose.

    Distribution: connection with plasma proteins. - more than 99% (most of it is associated with albumins). The apparent volume of distribution of diclofenac in the body is on average 0.12-0.55 l / kg. Penetrates into breast milk, synovial fluid; FROMmah in the synovial fluid is observed for 2-4 hours later, than at plasma. T1 / 2 from the synovial fluid - 3-6 h (the concentration of the drug in the synovial fluid after 4-6.ch after its administration is higher than in the plasma, and remain higher for another 12 h).

    Metabolism: 50% of the drug is metabolized during the "first pass" through the liver. Metabolism occurs as a result of multiple or single hydroxylation and conjugation with glucuronic acid! In the metabolism of the drug is also involved isoenzyme CYP2C9. The main metabolite is the drug (4'-hydroxydiclofenac) has a slight anti-inflammatory activity.

    Excretion: Systemic clearance is 260 ml / min. T1 / 2 from the plasma - 1-2 hours 60% of the administered dose is excreted as metabolites through the kidneys; less 1% is displayed unchanged, the rest of the dose is output as

    metabolites with bile.

    In patients with severe renal failure (creatinine clearance less than 10 ml / min), the excretion of metabolites with bile is increased, while there is no increase in their concentration in the blood. In patients with chronic hepatitis or compensated cirrhosis of the liver, the pharmacokinetic parameters do not change.

    Indications:
    Symptomatic treatment of pain syndrome and inflammation, such as:

    - arthritis (including rheumatoid), osteoarthritis, gout attacks;

    - periarthritis, tendonitis, tenosynovitis, bursitis; ,

    - post-traumatic and postoperative; pain syndrome accompanied by inflammation.
    Contraindications:
    - known hypersensitivity to diclofenac or to any of the excipients;

    - erosive and ulcerative lesions of the gastrointestinal tract (GIT), inflammatory bowel disease in the acute stage;

    - cerebrovascular bleeding or existing bleeding disorders;

    - oppression of bone marrow hematopoiesis;

    - acute heart failure;

    - Decompensated heart failure;

    - complete or incomplete combination of bronchial asthma, recurrent nasal polyposis and paranasal sinuses and intolerance to acetylsalicylic acid (ASA) or other NSAIDs (including in the anamnesis);

    - condition after aorto-coronary bypass surgery;

    - severe renal failure (clearance of cretinin less than 30 ml / min), progressive kidney disease;

    - severe hepatic impairment or active liver disease;

    - confirmed hyperkalemia;

    - III trimester of pregnancy and lactation;

    - children's age (up to 15 years).
    Carefully:Ulcerative colitis, medical history of the development of ulcerative lesions of the gastrointestinal tract, Crohn's disease, chronic liver failure, liver disease, a history of hepatic porphyria, chronic heart failure, arterial hypertension, a significant reduction in circulating blood volume (in fact, even after major surgery ), cerebrovascular disease, ischemic heart disease, peripheral artery disease, elderly patients (including those receiving diuretics, "weakened nnye patients with low body weight), bronchial asthma, simultaneous glucocorticosteroids (including prednisone), anticoagulants. (including warfarin), antiplatelet agents (including acetylsalicylic acid, clopidogrel), selective serotonin reuptake inhibitors (including including citalopram, fluoxetine, paroxetine, sertraline), dyslipidemia / hyperlipidemia, diabetes, the presence of Helicobacter pylori infection, prolonged use of NSAIDs, chronic renal failure (creatinine clearance less than 60 mL / min) Smoke ies, frequent use of alcohol, severe physical illnesses, pregnancy I-II trimester!
    Pregnancy and lactation:
    Complete data on the use of diclofenac during pregnancy are absent. Experiments on animals showed reproductive toxicity. The potential risk to humans is unknown. If possible, avoid the use of diclofenac in the first and second trimesters of pregnancy. In cases of emergency diclofenac should be taken at minimal therapeutic doses for a short period of time.
    Diclofenac is contraindicated in the third trimester of pregnancy. In connection with its mechanism of action, it is possible to suppress the ability of the myometrium to contract, prolong the period of pregnancy and childbirth, cardiovascular and renal toxicity of the fetus, and the appearance of a tendency for bleeding in the mother and child.
    Diclofenac and its derivatives penetrate breast milk in small amounts, and therefore a short-term drug intake without interruption of feeding is possible. In cases where longer dosing is required, as well as taking high doses, it is recommended to stop breastfeeding for a while.
    In connection with the negative effect on fertility, women who want to become pregnant, the drug is not recommended.In patients with infertility (including undergoing examination) it is recommended to cancel the drug.
    Dosing and Administration:
    Inside, entirely, on an empty stomach, without chewing and washing down with the necessary amount of liquid.
    Dosage depends on the severity of clinical manifestations. The recommended dose for adults and adolescents over 15 years is 75 to 150 mg diclofenac per day in one or two doses. The maximum single dose is 75 mg.
    With rheumatic diseases, it may be necessary to take diclofenac for a long time. In such cases it is recommended to reduce the daily dose of the drug as much as possible (up to 75 mg / day).
    Side effects:

    Often - 1-10%; not often - 0.1-1%, rarely - 0.01-0.1%, very rarely - less than 0.001%, including individual cases.

    It should be remembered that the intensity of side effects depends on the dose and varies in different patients. Risk of injury. The gastrointestinal tract (GIT) directly depends on the dose and duration of administration. The most common side effects are lesions GIT.

    From the digestive system: often - nausea, vomiting and diarrhea, dyspepsia, flatulence, anorexia, abdominal pain, increased activity of aminotransferases; rarely - gastrointestinal ulcers (with or without bleeding or perforation), gastritis, gastrointestinal bleeding, bloody vomiting,melena or bloody diarrhea, hepatitis, jaundice; very rarely - colitis (including colitis with blood, exacerbation of ulcerative colitis or Crohn's disease), constipation, stomatitis, glossitis, esophageal lesions, narrowing of the intestinal lumen, pancreatitis, fulminant hepatitis. "

    From the nervous system: often - headache, dizziness, weakness; rarely - drowsiness; very rarely - disorders of sensitivity (including paresthesia), memory disorders, convulsions, anxiety, tremor, aseptic meningitis, nightmares, depression, disorientation.

    From the sense organs: often - vertigo; very rarely - visual impairment (blurred vision, diplopia), hearing impairment, tinnitus, a violation of taste sensations.

    From the urinary system: very rarely - acute renal failure, hematuria, proteinuria, interstitial nephritis, nephrotic syndrome, papillary necrosis.

    Co sides of hemopoiesis: very rarely - hematopoietic disorders (hemolytic and aplastic anemia, leukopenia, agranulocytosis, thrombocytopenia).

    Allergic reactions: rarely anaphylactic / anaphylactoid reactions, including a marked decrease in blood pressure (BP) and shock; very rarely - angioedema (including face).

    From the cardiovascular system: very rarely - palpitation, chest pain, heart failure, increased blood pressure, vasculitis, myocardial infarction.

    From the respiratory system: rarely - bronchial asthma (including dyspnea); very rarely - pneumonia.

    From the skin: often - a rash; rarely - hives; very rarely - bullous eruptions, erythema, including multiform and Stevens-Johnson syndrome, Lyell's syndrome, exfoliative dermatitis, itching, hair loss, photosensitivity, purpura, including allergic.

    Other: rarely - swelling.

    Overdose:
    Symptoms: Central nervous system (CNS) disorders, such as headache, dizziness, drowsiness and loss of concentration. Pain in the abdomen, nausea, vomiting.
    There may also be bleeding in the gastrointestinal tract (GIT) and impaired liver and kidney function.
    Treatment: Therapeutic measures in case of an overdose. There is no special antidote.
    Interaction:The intake of diclofenac increases the concentration in the plasma of digoxin, lithium preparations.
    Reduces the effect of diuretics, against the background of potassium-sparing diuretics increases the risk of hyperkalemia; onbackground of anticoagulants, antiplatelet agents and thrombolytic drugs (alteplase, streptokinase, urokinase) increases the risk of bleeding (more often in the gastrointestinal tract).

    Reduces the effect of hypotensive and hypnotic drugs. Increases the likelihood of side effects (bleeding in the gastrointestinal tract) of other NSAIDs and glucocorticosteroids (GCS); toxicity of methotrexate and nephrotoxicity of cyclosporine due to an increase in their concentration in plasma.

    ASA reduces the concentration of diclofenac in the blood. Simultaneous use with paracetamol increases the risk of developing nephrotoxic effects of diclofenac.

    Reduces the effect of hypoglycemic drugs. Cefamandol, cefoperazone, cefotetan, valproic acid and plikamycin increase the incidence of hypoprothrombinemia.

    Selective serotonin reuptake inhibitors increase the risk of bleeding in the gastrointestinal tract. Simultaneous administration with ethanol, colchicine, corticotropin and preparations of St. John's wort increases the risk of bleeding in the gastrointestinal tract.

    Medicines that cause photosensitivity, increase the sensitizing effect of diclofenac to ultraviolet radiation.

    Drugs that block tubular secretion, increase the concentration in the plasma of diclofenac, thereby increasing its effectiveness and toxicity.

    Antibacterial drugs from the quinolone group increase the risk of seizures.

    Special instructions:
    Because of the important role of prostaglandins in maintaining renal blood flow, caution should be exercised in appointing patients with cardiac or renal insufficiency, and also in the treatment of elderly patients taking diuretics and patients who for any reason have a decrease in circulating blood volume (in including after extensive surgical intervention). If in such cases appoint diclofenac, recommend as a precautionary measure to monitor kidney function.

    In patients with renal insufficiency with CC less than 10 ml / min, the equilibrium concentration of metabolites in plasma should theoretically be significantly higher than in patients with normal renal function, but this is not really observed, since in this situation the excretion of metabolites with bile is enhanced.

    In patients with hepatic insufficiency (chronic hepatitis, compensated cirrhosis), the kinetics and metabolism do not differ from similar processes in patients with normal liver function. When performing long-term therapy, it is necessary to monitor liver function, the picture of peripheral blood, the analysis of feces for latent blood. To reduce the risk of developing adverse events from the gastrointestinal tract, a minimum effective dose should be used with the minimum possible short course.
    Effect on the ability to drive transp. cf. and fur:in the period of treatment, the speed of mental and motor reactions may be reduced, so it is necessary to refrain from driving motor vehicles and practicing other potentially dangerous activities that require an increased concentration of attention and speed of psychomotor reactions.
    Form release / dosage:Capsules intestine soluble 75 mg.
    Packaging:10 capsules per blister, made of PVC / PVDC film and aluminum foil. By 1, 2, 3 or 5 blisters together with
    Instructions for use are placed in a cardboard box.
    Storage conditions:At a temperature of no higher than 25 ° C. Keep out of the reach of children.
    Shelf life:
    4 years. Do not use after the expiration date.
    Terms of leave from pharmacies:On prescription
    Registration number:LP-001031
    Date of registration:18.10.2011
    Date of cancellation:2016-10-18
    The owner of the registration certificate:Delta Medikel Promotions AGDelta Medikel Promotions AG Switzerland
    Manufacturer: & nbsp
    Representation: & nbspRepresentation Delta Medikel Promotions AGRepresentation Delta Medikel Promotions AG
    Information update date: & nbsp12.02.2016
    Illustrated instructions
      Instructions
      Up